These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 6302487

  • 1. Spontaneous transmitter release in experimental neuromuscular disorders of the rat.
    Thesleff SW.
    Muscle Nerve; 1982; 5(9S):S12-6. PubMed ID: 6302487
    [Abstract] [Full Text] [Related]

  • 2. A new type of transmitter release at the neuromuscular junction.
    Thesleff S, Molgó J.
    Neuroscience; 1983 May; 9(1):1-8. PubMed ID: 6308500
    [Abstract] [Full Text] [Related]

  • 3. Calcium-insensitive miniature endplate potentials at the neuromuscular junction.
    Lupa MT.
    Synapse; 1987 May; 1(4):281-92. PubMed ID: 2843994
    [Abstract] [Full Text] [Related]

  • 4. Methylmercury-induced depression of neuromuscular transmission in the rat.
    Atchison WD, Narahashi T.
    Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
    [Abstract] [Full Text] [Related]

  • 5. Transmitter release in botulinum-poisoned muscles.
    Thesleff S.
    J Physiol (Paris); 1984 Nov; 79(4):192-5. PubMed ID: 6152289
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of action of lead on neuromuscular junctions.
    Atchison WD, Narahashi T.
    Neurotoxicology; 1984 Nov; 5(3):267-82. PubMed ID: 6097847
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological characterization of the calcium-insensitive, intermittent acetylcholine release at the rat neuromuscular junction.
    Tabti N, Lupa MT, Yu SP, Thesleff S.
    Acta Physiol Scand; 1986 Nov; 128(3):429-36. PubMed ID: 3788620
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Further evidence for the dynamic formation of transmitter quanta at the neuromuscular junction.
    Vautrin J, Kriebel ME, Holsapple J.
    J Neurosci Res; 1992 Jun; 32(2):245-54. PubMed ID: 1357188
    [Abstract] [Full Text] [Related]

  • 17. Alterations of spontaneous and evoked release of acetylcholine during dithiobiuret-induced neuromuscular weakness.
    Atchison WD.
    J Pharmacol Exp Ther; 1989 Jun; 249(3):735-43. PubMed ID: 2499675
    [Abstract] [Full Text] [Related]

  • 18. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.
    Engel AG, Lambert EH, Gomez MR.
    Ann Neurol; 1977 Apr; 1(4):315-30. PubMed ID: 214017
    [Abstract] [Full Text] [Related]

  • 19. Effects of botulinum toxin on neuromuscular transmission in the rat.
    Cull-Candy SG, Lundh H, Thesleff S.
    J Physiol; 1976 Aug; 260(1):177-203. PubMed ID: 184273
    [Abstract] [Full Text] [Related]

  • 20. Giant miniature endplate potentials induced by 4-aminoquinoline.
    Molgó J, Gomez S, Polak RL, Thesleff S.
    Acta Physiol Scand; 1982 Jun; 115(2):201-7. PubMed ID: 7136813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.